OABI OmniAb, Inc. - Common Stock
$2.54
Price · May 20, 2026
Fundamentals as of May 7, 2026
52W Range
$1–$3
98% of range
Analyst Rating
BUY
13 analysts
Price Target
$7
+189% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
OABI Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$2.54
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$1 – $3
OABI Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
OABI
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
OABI
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
OABI
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
OABI
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
OABI
Peer Median
OABI Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
13 analysts
- Strong Buy 4 30.8%
- Buy 8 61.5%
- Hold 1 7.7%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
6 analysts · 2026-05-16
Median
$8.00
Mean
$7.33
← Below all targets
$2.54
Low
$3.00
High
$11.00
Median target
$8.00
+215.6%
Mean target
$7.33
+189.3%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.01%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.06 | $-0.10 | 0.04% |
| Dec. 31, 2025 | $-0.11 | $-0.09 | -0.02% |
| Sept. 30, 2025 | $-0.14 | $-0.14 | 0.00% |
| June 30, 2025 | $-0.15 | $-0.16 | 0.01% |
| March 31, 2025 | $-0.17 | $-0.17 | -0.00% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| OABI | — | — | — | — | — | — |
| CYRX | $479M | 6.9 | 12.4% | 44.4% | 15.3% | 47.1% |
| MLAB | $647M | -329.6 | 11.5% | -0.82% | -1.2% | 62.6% |
| CTKB | $649M | 505.0 | 0.52% | -33.0% | -18.5% | 51.8% |
| DNA | $484M | -1.5 | -25.1% | -183.8% | -55.8% | — |
| LAB | $495M | -6.4 | -6.2% | -87.8% | -17.6% | 49.9% |
| PACB | $565M | -1.0 | 3.9% | -341.5% | -1634.9% | 28.6% |
| NAUT | $247M | -4.1 | — | — | -34.9% | — |
| CDXS | $147M | -3.3 | 18.6% | -62.5% | -82.8% | — |
| TKNO | $204M | -11.9 | 7.3% | -42.6% | -23.8% | 33.2% |
| QSI | — | — | — | — | — | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 15
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Revenue | $14M | $4M | |
| R&D Expense | $10M | $13M | |
| SG&A Expense | $7M | $8M | |
| Operating Expenses | $22M | $23M | |
| Operating Income | $-8M | $-19M | |
| Interest Income | $487.0K | $537.0K | |
| Other Non-op | $77.0K | $1.0K | |
| Pretax Income | $-7M | $-18M | |
| Income Tax | $442.0K | $-106.0K | |
| Net Income | $-8M | $-18M | |
| EPS (Basic) | $-0.06 | $-0.17 | |
| EPS (Diluted) | $-0.06 | $-0.17 | |
| Shares (Basic) | 128,245,000 | 105,622,000 | |
| Shares (Diluted) | 128,245,000 | 105,622,000 | |
| EBITDA | $-8M | · |
Balance Sheet 27
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Cash & Equivalents | $29M | · | |
| Receivables | $13M | · | |
| Inventory | $920.0K | · | |
| Prepaid Expense | $3M | · | |
| Other Current Assets | $472.0K | · | |
| Current Assets | $65M | · | |
| PP&E (Net) | $9M | · | |
| PP&E (Gross) | $29M | · | |
| Accum. Depreciation | $20M | · | |
| Goodwill | $84M | · | |
| Intangibles | $119M | · | |
| Other Non-current Assets | $795.0K | · | |
| Total Assets | $294M | · | |
| Accounts Payable | $2M | · | |
| Accrued Liabilities | $4M | · | |
| Current Liabilities | $14M | · | |
| Capital Leases | $16M | · | |
| Deferred Tax | $1M | · | |
| Other Non-current Liabilities | $75.0K | · | |
| Total Liabilities | $31M | · | |
| Common Stock | $14.0K | · | |
| Paid-in Capital | $437M | · | |
| Retained Earnings | $-174M | · | |
| AOCI | $-2.0K | · | |
| Stockholders' Equity | $263M | · | |
| Liabilities + Equity | $294M | · | |
| Shares Outstanding | 144,783,813 | · |
Cash Flow 8
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Stock-based Comp | $3M | $4M | |
| Amort. of Intangibles | $6M | $3M | |
| Operating Cash Flow | $-5M | $-16M | |
| CapEx | $167.0K | $209.0K | |
| Investing Cash Flow | $8M | $-878.0K | |
| Financing Cash Flow | $0 | $44.0K | |
| Net Change in Cash | $4M | $-17M | |
| Free Cash Flow | $-5M | · |
Profitability 7
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Operating Margin | -54.3% | · | |
| Net Margin | -53.4% | · | |
| Pretax Margin | -50.4% | · | |
| EBITDA Margin | -54.3% | · | |
| ROA | -2.6% | · | |
| ROE | -2.9% | · | |
| ROIC | -3.2% | · |
Liquidity & Solvency 2
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Current Ratio | 4.8 | · | |
| Quick Ratio | 3.1 | · |
Efficiency 2
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Asset Turnover | 0.0 | · | |
| Receivables Turnover | 1.5 | · |
Valuation (TTM) 10
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Revenue TTM | $25M | · | |
| Net Income TTM | $-58M | · | |
| Market Cap | $227M | · | |
| P/E | -3.0 | · | |
| P/S | 9.2 | · | |
| P/B | 0.9 | · | |
| P / Tangible Book | 3.8 | · | |
| P / Cash Flow | -46.3 | · | |
| P / FCF | -44.7 | · | |
| Earnings Yield | -33.1% | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.